Health Trials

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

ConditionCongenital Myasthenic Syndrome
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Foundation for Orthopaedics and Regenerative Medicine

About this trial

Patients with Congenital Myasthenic Syndrome will be treated with Mesenchymal Stem Cell Exosome solution.

Eligibility criteria

Qualifiers

Patients will need a diagnosis of Congenital Myasthenic Syndrome by a licensed physician.

Patients must be able to provide informed consent, or have a guardian who does.

Patient must be able to travel to the site of treatment.

Disqualifiers

Patients will be excluded from the trial if they are pregnant or have active cancer (malignancy) at the screening consultation.

Trial design

Treatments tested in this trial

  • AlloEx exosomes

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

The Foundation for Orthopaedics and Regenerative Medicine

Lead sponsor

Source ClinicalTrials.gov